|
EDRN
Genitourinary (GU) Prostate Collaborative Group Meeting
Theme:
Aligning Science and Strategy to Advance Prostate Cancer Early Detection
within EDRN
The
University of Texas MD Anderson Cancer Center, Houston, Texas
Wednesday,
March 4, 2026 – 3:15pm – 6:15pm CT
Location: Room
CPB8 Rms 5-6
|
|
Chair: Jeffrey J Tosoian, MD, Vanderbilt
University Medical Center
Co-Chair: O. John Semmes, PhD, Old Dominion
University
NCI Program Directors: Indu Kohaar, PhD, National Cancer
Institute
DMCC: Yingye Zheng, PhD, Kristin Rodgers, Fred
Hutchinson Cancer Center
|
|
Wednesday, March 4, 2026
|
|
Start
|
End
|
Title /
Topic
|
Presenter /
Institution
|
Number
|
|
3:15pm
|
3:25pm
|
Welcome and Framing of Discussion
|
Indu Kohaar, PhD, National Cancer Institute;
Jeffrey Tosoian, MD, Vanderbilt University Medical Center
|
N/A
|
|
|
4:05pm
|
Industry Talks on
Potential Collaborations (40 min – 10 min each)
|
|
3:25pm
|
3:35pm
|
Creatv MicroTech,
Inc.
Expanding the Clinical Utility of Blood Based Biopsies
in Cancer Screening, Diagnostics and Drug Prediction Using Circulating
Stromal Cells
|
Daniel L. Adams, Chief Scientific Officer, Creatv Bio,
Division of Creatv MicroTech
|
01
|
|
3:35pm
|
3:45pm
|
Meso Scale
Diagnostics, LLC
Bridging Discovery and Validation in Prostate Cancer
Biomarkers
|
Hans Layman, PhD, Executive Director Oncology &
Scientific Affairs, Meso Scale Diagnostics, LLC
|
02
|
|
3:45pm
|
3:55pm
|
Beckman Coulter
Advancing Prostate Care: phi at Beckman Coulter
|
Lindsay Sun, MD, Senior Medical Director, Beckman
Coulter
|
03
|
|
3:55pm
|
4:05pm
|
Alluz Diagnostics
Clinical Translation for Prostate Cancer Tests to
Address High Unmet Clinical Needs
|
Gerard Davis, PhD, Alluz Diagnostics
|
03
|
|
4:05 pm
|
4:45 pm
|
Cross-Center and Industry Collaborations
|
Martin Sanda, MD, Emory University
John Semmes, PhD, Eastern Virginia Medical School
|
05
|
|
4:45 pm
|
4:55 pm
|
BREAK
|
BREAK
|
BREAK
|
|
4:55 pm
|
5:25 pm
|
Promising
Approaches and PCa Biomarkers
|
Dan Chan, PhD, Hui
Zhang, PhD
Johns Hopkins
University
|
06
|
|
5:25 pm
|
5:45 pm
|
NCI EDRN MRI
Biomarker Study and Reference Set (PMRI)- Status and Potential Outcome
|
John Wei, MD; Simpa
Salami, MD
University of
Michigan
|
07
|
|
5:45 pm
|
6:15 pm
|
Vision for Next
Cycle of EDRN
|
Indu Kohaar, PhD, National Cancer Institute;
Jeffrey Tosoian, MD, Vanderbilt University Medical Center
|
08
|
|
6:15p
|
ADJOURN
|
